HIGHLIGHTS
- who: Aaron Wetten et al. from the Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK have published the research: Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?, in the Journal: Canadian Journal of Gastroenterology and Hepatology of 13/06/2022
- what: In this study, the relationship between PBC-associated cognitive symptoms and allopregnanolone was explored to examine whether this potentially modifable pathway could be a target for novel therapies.
- future: Given the emerging data that golexanolone improves cognitive symptoms through the antagonistic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.